Microbial-derived metabolites produced by the skin microbiome, such as short-chain fatty acids and tryptophan-derived ligands, may modulate cutaneous signaling pathways including AhR activation and cytokine profiles, and are linked to variation in skin sensitivity and inflammatory responses.